# Intravenous Estrogen in Kidney Transplant Study

> **NCT03663543** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 30 (estimated)

## Conditions studied

- Ischemia Reperfusion Injury

## Interventions

- **DRUG:** Conjugated Estrogen
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03663543
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08-26
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-05-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663543, "Intravenous Estrogen in Kidney Transplant Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03663543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*